Rudolf Stadler
Hautklinik
Klinikum Minden
Germany
Name/email consistency: high
- Therapeutic advances in cutaneous T-cell lymphoma (CTCL): from retinoids to rexinoids. Stadler, R., Kremer, A. Semin. Oncol. (2006)
- Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial. Stadler, R., Luger, T., Bieber, T., Köhler, U., Linse, R., Technau, K., Schubert, R., Schroth, K., Vakilzadeh, F., Volkenandt, M., Gollnick, H., Von Eick, H., Thoren, F., Strannegård, O. Acta. Oncol (2006)









